Watch Now
NewsCoronavirus

Actions

Reports: FDA to consider boosters for the immunocompromised

Multiple reports say the FDA is planning to review CDC data in the next week or so.
vaccine
Scripps file photo
Around 3,000 Arizonans are participating in a COVID-19 study run out of the University of Arizona.
vaccine
Posted
and last updated

The FDA could approve vaccine booster shots for some of the most vulnerable Americans within weeks. 

According to multiple reports, in the next week or so, the FDA is planning to review CDC data on additional doses for the immunocompromised.

That includes people who have gotten organ transplants, are being treated for cancer, or have HIV, just to name a few. 

This story was originally reported by Kamil Zawadzki on Newsy.com

Newsy 2021

SIGN UP   ► NEWSLETTERS    
► NEWS ALERTS  

Coronavirus Section Quick Links

When, where you'll need to wear face coverings Coronavirus aid: How to help your neighbors Cold vs. Flu vs. Coronavirus Symptoms INTERACTIVE MAP: San Diego County COVID-19 Cases HEAT MAP: COVID-19 cases in San Diego In-Depth: Getting vaccinated via healthcare providers In-Depth: How to book a vaccine for someone else Alternative sites to get a COVID-19 vaccination In-Depth: Treating COVID-19 symptoms at home In-Depth: COVID vaccine and pregnancy/lactation How the five leading COVID vaccines compare In-Depth: COVID vaccine side effects In-Depth: San Diego's 'vaccine gap' for minority leaders In-Depth: Doctors discuss long-term effects of COVID-19